---
schema_version: "secwatch.filing_event.v1"
accession: "0001425450-25-000047"
form_type: "8-K"
ticker: "KIDS"
cik: "0001425450"
company_name: "ORTHOPEDIATRICS CORP"
filed_at: "2025-05-07T23:59:59+00:00"
generated_at: "2026-05-22T07:32:02.684838+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# OrthoPediatrics Q1 revenue $52.4M (+17% YoY); raises FY2025 guidance to $236-242M

## Summary
- Total Q1 revenue $52.4M (+17% YoY); U.S. revenue $40.9M (+19%), international $11.5M (+11%).
- Net loss $10.7M ($0.46 per share) vs. $7.8M ($0.34) in Q1 2024; adjusted EBITDA loss improved to ($0.4M) from ($1.1M).
- FY2025 revenue guidance raised to $236M-$242M (15-18% growth); adjusted EBITDA guidance reiterated at $15-17M.
- Scoliosis revenue grew 34% to $13.7M; launched VerteGlide system for Early Onset Scoliosis.
- Cash, equivalents and restricted cash $60.8M at quarter end vs. $70.8M at Dec 31, 2024.

## SEC filing metadata
- accession: 0001425450-25-000047
- form_type: 8-K
- ticker: KIDS
- cik: 0001425450
- company_name: ORTHOPEDIATRICS CORP
- filed_at: 2025-05-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1425450/000142545025000047/0001425450-25-000047-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1425450/000142545025000047/kids-20250507.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001425450-25-000047
- JSON: https://secwatch.observer/filing/0001425450-25-000047.json
- Plain text: https://secwatch.observer/filing/0001425450-25-000047.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.